Melatonin night shift workers may gain a new tool against cancer risk: a first-of-its-kind trial found that 3 mg before ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

PSA test detects benign cancers which can result in men having radiotherapy, surgery or hormone therapy, putting them at risk of complications such as incontinence and impotence ...

Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to acquire BioProtect Ltd. (BioProtect), a ...

A leading researcher working on the prevention and early detection of common cancers has been elected as a Fellow of the ...

Paul Kelly, consultant radiation oncologist and medical director, Bon Secours Radiotherapy Centre and UPMC Hillman Cancer ...

Japanese medical device company Olympus Corporation announced today it has signed a definitive agreement to acquire Israeli ...

Montelukast, a popular asthma medication, has been shown to inhibit the spread of cancer by blocking a molecule that helps ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

Asthma drug montelukast may help improve immunotherapy by stopping tumors from hijacking immune cells, offering hope for ...

Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...

Multivitamins can support normal growth and function in the body, but not everyone needs to take them daily to support ...